Drug-eluting stents safer than metallic ones in preventing cardiac deaths
March 29th, 2009 - 1:58 pm ICT by IANSWashington, March 29 (IANS) Drug-eluting stents (DES) were found to be safer and superior than bare metal stents in preventing death and heart attacks among 262,700 patients enrolled in a nationwide registry of cardiovascular disease.
These results have been validated by the largest study of its kind, conducted by the Duke University Medical Centre (DUMC), which may end years of controversy over the safety of the devices.
Stents are small tubes that can prop open blocked coronary arteries. The earliest versions were made of bare metal mesh, but later models were designed to release a medication that could suppress the growth of restenosis, new tissue that could clog up the arteries again.
After initially proving more effective than bare metal stents (BMS) in preventing restenosis, DES suffered a setback when recent clinical trials found them associated with higher long-term death rates.
“We hope these findings will finally lay to rest any doubt about the safety of drug-eluting stents,” said Pamela Douglas, cardiologist and member of the Heart Centre at DUMC and the study’s lead author. “Our results clearly show that drug-eluting stents are indeed safe.”
Douglas and colleagues followed patients over age 65 enrolled in the National Cardiovascular Data Registry who received stents from 2004 to 2006.
Most of the patients received a DES; only 17 percent were implanted with BMS variety. Investigators matched the patients’ data with their Medicare claims and followed them for two-and-a-half years, measuring rates of death, heart attack, stroke, bleeding and the need for additional artery-opening procedures.
They found that over the 30-month period, patients in the DES group had a 25 percent reduction in death and 24 percent reduction in heart attacks, when compared with those who received BMS, but no significant difference in the incidence of stroke, major bleeding or need for additional artery-opening procedures, said a DUMC release.
The findings appear online in the Journal of the American College of Cardiology.
- Drug-eluting stents safer and superior to bare metal stents - Mar 29, 2009
- Drug-eluting stents safe for long-term use in angioplasty patients - Aug 19, 2010
- Drug-eluting stents found to be superior in efficacy to bare metal stents Home - May 27, 2009
- Drug-eluting stents found to be superior in efficacy to bare metal stents - May 07, 2009
- New way to treat heart blocks: Drug eluting balloon - Sep 18, 2011
- Drug-eluting stents safer than bare-metal ones for heart patients - Sep 26, 2009
- Drug-eluting stents more effective, equally as safe as bare metal ones - Oct 16, 2008
- Drug-coated stents less risky for heart bypass patients - Jan 22, 2009
- Everolimus-eluting stent safer, more effective than paclitaxel-eluting stent - May 06, 2010
- More strokes, fewer heart attacks with carotid stents: Study - Oct 12, 2010
- Drug eluting stents do make for better angioplasty outcomes - Dec 19, 2008
- Researcher develops biodegradable stent for hearts patients - Nov 25, 2009
- Drug-coated stents safer for bypass patients - Jan 22, 2009
- Drug-eluting stents as safe and effective than bare-metal ones - Nov 20, 2007
- Stents as good as surgery for unclogging carotid arteries - Feb 27, 2010
Tags: bare metal stents, bms, cardiac deaths, cardiologist, cardiovascular disease, coronary arteries, death rates, drug eluting stents, duke university medical, duke university medical centre, dumc, heart attack, heart attacks, heart centre, medicare claims, metal mesh, patients data, setback, two and a half years, university medical centre
